Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2008 2
2009 3
2010 6
2011 8
2012 7
2013 6
2014 4
2015 1
2016 5
2018 5
2019 3
2020 7
2021 3
2022 12
2023 7
2024 3

Text availability

Article attribute

Article type

Publication date

Search Results

67 results

Results by year

Filters applied: . Clear all
Page 1
Dupilumab in the treatment of severe uncontrolled chronic rhinosinusitis with nasal polyps (CRSwNP): A multicentric observational Phase IV real-life study (DUPIREAL).
De Corso E, Pasquini E, Trimarchi M, La Mantia I, Pagella F, Ottaviano G, Garzaro M, Pipolo C, Torretta S, Seccia V, Cantone E, Ciofalo A, Lucidi D, Fadda GL, Pafundi PC, Settimi S, Montuori C, Anastasi F, Pagliuca G, Ghidini A, Cavaliere C, Maffei M, Bussu F, Gallo S, Canevari FRM, Paludetti G, Galli J; Dupireal Italian Study Group. De Corso E, et al. Among authors: seccia v. Allergy. 2023 Oct;78(10):2669-2683. doi: 10.1111/all.15772. Epub 2023 May 26. Allergy. 2023. PMID: 37203259
S. aureus and IgE-mediated diseases: pilot or copilot? A narrative review.
Calabrese C, Seccia V, Pelaia C, Spinelli F, Morini P, Rizzi A, Detoraki A. Calabrese C, et al. Among authors: seccia v. Expert Rev Clin Immunol. 2022 Jun;18(6):639-647. doi: 10.1080/1744666X.2022.2074402. Epub 2022 May 9. Expert Rev Clin Immunol. 2022. PMID: 35507006 Review.
Remission in Type 2 Inflammatory Diseases: Current Evidence, Unmet Needs, and Suggestions for Defining Remission in Chronic Rhinosinusitis with Nasal Polyps.
Caminati M, De Corso E, Ottaviano G, Pipolo C, Schiappoli M, Seccia V, Spinelli FR, Savarino EV, Gisondi P, Senna G. Caminati M, et al. Among authors: seccia v. Curr Allergy Asthma Rep. 2024 Jan;24(1):11-23. doi: 10.1007/s11882-023-01118-6. Epub 2023 Dec 12. Curr Allergy Asthma Rep. 2024. PMID: 38085499 Free PMC article. Review.
Practical recommendations for managing severe chronic rhinosinusitis with nasal polyps in the era of biologics.
De Corso E, Pipolo C, Cantone E, Ottaviano G, Gallo S, Trimarchi M, Torretta S, Cavaliere C, Lucidi D, Seccia V, Settimi S, Canevari FRM, Pasquini E, La Mantia I, Garzaro M, Bellocchi G, De Benedetto M, Lombardo N, Macchi A, Malvezzi L, Motta G, Vicini C, Maselli A, Dell'Era V, Dragonetti A, Asprea F, Lupato V, Ghidini A, Masieri S, Mattavelli D, Salzano FA, Passali D, Galli J, Pagella F. De Corso E, et al. Among authors: seccia v. Acta Otorhinolaryngol Ital. 2023 Oct;43(5):324-340. doi: 10.14639/0392-100X-N2422. Epub 2023 May 23. Acta Otorhinolaryngol Ital. 2023. PMID: 37224173 Free PMC article.
67 results